Related by context. Frequent words. (Click for all words.) 86 placebo controlled 84 randomized double 83 randomized controlled 80 blind randomized 80 blind randomized placebo 80 double blind placebo 79 multicenter 79 randomized clinical 78 prospective randomized 77 randomized 74 blind placebo controlled 74 randomized controlled trial 69 dose escalation study 68 Phase 2b study 67 multicenter study 67 Phase 2a clinical 66 Phase III clinical 66 Phase IIb trial 66 randomized clinical trials 66 randomized Phase 65 clinical trial 65 Phase IIb 65 Phase 2b clinical 64 randomized controlled trials 64 pivotal Phase III 64 prospective cohort 63 Phase Ib 63 pivotal Phase 63 Phase IIb clinical 63 Phase IIa trial 63 Phase 2b 63 Phase 1b 62 randomized trials 62 Phase IIa 62 dose escalation 62 mg dose 61 Phase IIa clinical 61 safety tolerability 61 Phase III 61 observational study 61 tolerability 61 Phase 2a 59 pharmacodynamics 59 pharmacokinetic 58 meta analysis 58 non inferiority 57 placebo 57 monotherapy 57 Phase III clinical trials 57 RG# [001] 56 post hoc 56 Phase III trials 56 pharmacokinetics 56 dose regimen 56 observational studies 56 relapsing remitting multiple sclerosis 56 dosing regimens 56 primary endpoint 56 rosuvastatin 56 ACTEMRA 55 efficacy 55 Efficacy 55 Phase II 55 relapsing remitting MS 55 evaluable patients 54 pharmacodynamic 54 citalopram 54 randomly assigned 54 clinical trials 54 secondary endpoint 54 antiviral activity 54 primary endpoints 54 n = 54 primary efficacy endpoint 54 sunitinib 53 pharmacokinetic profile 53 tolerability profile 53 DSMB 53 laquinimod 53 demonstrated statistically significant 53 Clinical Study 53 postmenopausal women 53 pioglitazone 53 etanercept 52 bevacizumab 52 sitagliptin 52 SEROQUEL 52 docetaxel 52 pegylated interferon 52 allopurinol 52 meta analyzes 52 investigational compound 52 TMC# [001] 52 IDX# 52 ofatumumab 52 longitudinal study 51 Phase 51 orally administered 51 donepezil 51 acute ischemic stroke 51 temozolomide